780
Participants
Start Date
August 3, 2023
Primary Completion Date
June 30, 2025
Study Completion Date
October 31, 2025
Recombinant Mycobacterium Tuberculosis Fusion Protein
"Dosage form:injection. Main ingredients and contents: Recombinant Mycobacterium tuberculosis fusion protein, 0.3ml, 0.5ml, 1.0ml per bottle.~1\. This product is used alone: 0.1ml (5U) of this product is inhaled and injected into the palmar skin of the forearm by the Mondu's method. 2. This product combined with TB-PPD: 0.1ml(5U) of this product and 0.1ml(5U) of TB-PPD were inhaled respectively, and the product was injected intradermally into the volar side of the left forearm by the Mondu's method. After observing no abnormality for 5 minutes, TB-PPD was injected intradermally into the volar side of the right forearm."
Purified Protein Derivative of Tuberculin
"Dosage form:injection. Main ingredients and contents:Pure protein derivatives of tuberculin,0.1ml per bottle.~Usage:0.1ml (5IU) of this product is inhaled and injected into the palmar skin of the forearm by the Mondu's method."
RECRUITING
The First Affiliated Hospital of Bengbu Medical University, Bengbu
NOT_YET_RECRUITING
Anhui Chest Hospital, Hefei
RECRUITING
Guangzhou Municipal Hospital of Chest Medicine, Guangzhou
RECRUITING
The Third People's Hospital Of Shenzhen, Shenzhen
RECRUITING
LiuZhou People's Hospital, Liuzhou
RECRUITING
Changsha Central Hospital, Changsha
RECRUITING
Wuxi NO.5 People's Hospital, Wuxi
RECRUITING
Wuhan Institute for Tuberculosis Control, Wuhan
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
INDUSTRY